High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

Clinical trial NCT06418789 · RECRUITING

Trial details

NCT number: NCT06418789
Sponsor: N.N. Petrov National Medical Research Center of Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor

Start date: 2024-03-01
Primary completion: 2029-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.